Organoids for Functional Precision Medicine in Advanced Pancreatic Cancer
Alice Boilève(Inserm), Jérôme Cartry(Inserm), Negaar Goudarzi(Inserm), Sabrina Bedja(Inserm), Jacques R.R. Mathieu(Inserm), Mohamed Amine Bani(Institut Gustave Roussy), Rémy Nicolle(Centre National de la Recherche Scientifique), Ali Mouawia(Inserm), Ryme Bouyakoub(Institut Gustave Roussy), Claudio Nicotra(Institut Gustave Roussy), Maud Ngo‐Camus(Institut Gustave Roussy), Bastien Job(Institut Gustave Roussy), Karélia Lipson(Institut Gustave Roussy), V. Boige(Institut Gustave Roussy), Marine Valéry(Institut Gustave Roussy), Anthony Tarabay(Institut Gustave Roussy), Peggy Dartigues(Institut Gustave Roussy), Lambros Tselikas(Institut Gustave Roussy), Thierry de Baère(Institut Gustave Roussy), Antoîne Italiano(Institut Gustave Roussy), Simona Cosconea(Institut Gustave Roussy), Maximiliano Gelli(Institut Gustave Roussy), Elena Fernandez-De-Sevilla(Institut Gustave Roussy), Maxime Annereau(Institut Gustave Roussy), David Malka(Inserm), Cristina Smolenschi(Institut Gustave Roussy), Michel Ducreux(Inserm), Antoine Hollebecque(Institut Gustave Roussy), Fanny Jaulin(Inserm)
Cited by 82Open Access
Abstract
Related Papers
From FastQ Data to High‐Confidence Variant Calls: The Genome Analysis Toolkit Best Practices Pipeline
Géraldine Van der Auwera, Mauricio O. Carneiro, Christopher Hartl et al.|Current Protocols in Bioinformatics|2013|7.2k
Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
Daniel D. Von Hoff, Thomas J. Ervin, Francis P. Arena et al.|New England Journal of Medicine|2013|6.6k